Literature DB >> 873619

Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters.

J V Jemski, C M Hetsko, C M Helms, M B Grizzard, J S Walker, R M Chanock.   

Abstract

The distribution of Mycoplasma pneumoniae infection in the respiratory tract and the extent of pulmonary pathology were determined by the site of deposition and the number of organisms administered to hamsters. Infection of the upper and lower areas of the respiratory tract occurred when organisms were introduced into both areas by small-particle aerosol (2.3 micrometer) or by intranasal (i.n.) instillation of a 200-microliter inoculum. In contrast, when organisms were delivered primarily to the upper respiratory tract by large-particle aerosol (8 micrometer) or by i.n. instillation of a small volume of inoculum (2 or 20 microliter), infection remained limited to this area in most or all instances. When the lungs became infected after i.n. administration of a 200-microliter inoculum, the most extensive pulmonary lesions were seen in the animals given the largest number of organisms. Each of the modes of administration of M. pneumoniae initiated an infection which conferred measurable resistance to a subsequent challenge capable of inducing extensive pulmonary disease. The most effective resistance was induced by the two modes of administration which produced an infection involving the entire respiratory tract, i.e., small-particle aerosol or i.n. instillation of a 200-microliter inoculum.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 873619      PMCID: PMC421493          DOI: 10.1128/iai.16.1.93-98.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Modifications to the Henderson apparatus for studying air-borne infections. Evaluations using aerosols of Listeria monocytogenes.

Authors:  W G ROESSLER; D A KAUTTER
Journal:  J Infect Dis       Date:  1962 Jan-Feb       Impact factor: 5.226

2.  Respiratory infections due to Mycoplasma pneumoniae in infants and children.

Authors:  G W Fernald; A M Collier; W A Clyde
Journal:  Pediatrics       Date:  1975-03       Impact factor: 7.124

3.  Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine.

Authors:  H Greenberg; C M Helms; M B Grizzard; W D James; R L Horswood; R M Chanock
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

4.  Modified spinning top homogeneous spray apparatus for use in experimental respiratory disease studies.

Authors:  H W Young; E W Larson; J W Dominik
Journal:  Appl Microbiol       Date:  1974-12

5.  Immunologic aspects of experimental Mycoplasma pneumoniae infection.

Authors:  G W Fernald
Journal:  J Infect Dis       Date:  1969-03       Impact factor: 5.226

6.  Asymptomatic infection of adult volunteers with a temperature sensitive mutant of Mycoplasma pneumoniae.

Authors:  H Greenberg; C M Helms; H Brunner; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

7.  Mycoplasma pneumoniae infections in volunteers.

Authors:  C B Smith; R M Chanock; W T Friedewald; R H Alford
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

8.  Temperature-sensitive mutants of Mycoplasma pneumoniae. II. Response of hamsters.

Authors:  P Steinberg; R L Horswood; H Brunner; R M Chanock
Journal:  J Infect Dis       Date:  1971-08       Impact factor: 5.226

Review 9.  Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control.

Authors:  F W Denny; W A Clyde; W P Glezen
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

10.  Influenza virus population dynamics in the respiratory tract of experimentally infected mice.

Authors:  E W Larson; J W Dominik; A H Rowberg; G A Higbee
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

View more
  7 in total

1.  Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine.

Authors:  H Greenberg; C M Helms; M B Grizzard; W D James; R L Horswood; R M Chanock
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

2.  Transmissibility of Mycoplasma dispar under experimental conditions.

Authors:  R Tanskanen
Journal:  Acta Vet Scand       Date:  1987       Impact factor: 1.695

3.  Mycoplasma pneumoniae-induced hydrocephalus in hamsters.

Authors:  D F Kohn; N Chinookoswong; J Wang
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

4.  Characterization of hemadsorption-negative mutants of Mycoplasma pneumoniae.

Authors:  E J Hansen; R M Wilson; W A Clyde; J B Baseman
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

5.  Protective effect of vaccination against Mycoplasma pulmonis respiratory disease in rats.

Authors:  G H Cassell; J K Davis
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

6.  Development of an aerosol model of murine respiratory mycoplasmosis in mice.

Authors:  J K Davis; R B Thorp; R F Parker; H White; D Dziedzic; J D'Arcy; G H Cassell
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

7.  Experimental infection of the respiratory tract with Mycoplasma pneumoniae.

Authors:  P C Hu; J M Kirtz; D E Gardner; D A Powell
Journal:  Environ Health Perspect       Date:  1980-04       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.